Alcidion Group (ASX: ALC) — Company Overview, News & Financial Data
Alcidion Group provides clinical decision support solutions through its Miya Precision platform for healthcare organizations.
Alcidion Group
Alcidion Group is a healthcare technology company that provides clinical informatics, health data integration, and smart software solutions for healthcare organisations. The company's core platform, Miya Precision, uses Fast Healthcare Interoperability Resources (FHIR) standards and real-time data integration to provide clinical decision support, predictive analytics, and operational visibility across acute, virtual, and community care settings. Alcidion offers modular digital solutions including patient flow management, electronic health records, virtual care monitoring, emergency department management, and clinical workflow enablement tools. The company serves public and private healthcare providers across Australia, New Zealand, and the United Kingdom.
Snapshot
Operations
Products and/or services of Alcidion Group
- Patient Flow Management: Digital electronic journey boards and patient flow software that provide real-time visibility into bed capacity, patient tracking, discharge planning, and site management to reduce administrative overhead and streamline hospital bed turnover across acute healthcare facilities.
- Virtual Care & Remote Monitoring: Telehealth and remote patient monitoring software platforms enabling clinical teams to track high-risk outpatients, monitor vital signs, manage chronic diseases, and deliver home-based acute care programs to reduce emergency admissions and regional patient travel.
- Smart Operations Centres: Enterprise-wide operational intelligence dashboards that consolidate real-time data across healthcare networks to coordinate patient movement, manage health system capacity, optimize staff allocation, and improve regional health service resource management during high-demand periods.
- Specialised Care & Emergency Solutions: Emergency department clinical software systems that streamline patient triage, monitor wait times, manage clinical tracking, and accelerate emergency department throughput to meet targeted four-hour admission or discharge operational performance standards in hospital environments.
- Modular Electronic Patient Records: Cloud-native electronic patient record and patient administration software modules providing longitudinal patient record integration, clinical history aggregation, FHIR-standard interoperability, and modular administration tools designed to replace or enhance legacy electronic medical record infrastructure.
- Clinical Workflows & Mobile Communication: Mobile clinical messaging, electronic observations, clinical risk screening, and task management tools enabling care teams to record vital signs, trigger automated deterioration alerts, capture clinical notes, and streamline doctor-nurse communications at the bedside.
Alcidion Group executive team
- Kate QuirkeGroup MD, CEO & Executive Director
- Matthew GeppChief Financial Officer
- Julia StevensChief Operating Officer
- Sean WalkerChief Technology Officer
- Nick WhiteChief Marketing Officer
- Amanda JamesChief People Officer
- Kaye HockingChief Product Officer
- Paul DeffleyChief Medical Officer & MD of UK
- Tracy McClellandChief Clinical Information Officer
- Michael SapountzisCompany Secretary
Latest news about Alcidion Group
Alcidion grows contracted revenue to $50M
AustraliaAlcidion Group reports $51.6M FY26 revenue
AustraliaAlcidion Group reports June quarterly cash flow of $7.7M
AustraliaAlcidion secures $35M UK health tech contract
AustraliaAlcidion Group chosen as preferred EPR supplier for University Hospitals Sussex
Australia
Recent announcements
What Alcidion Group (ALC) has told the market, newest first.
- Consolidation/Split - ALC
- Proposed Consolidation of CapitalPrice sensitive
- 2026 Notice of Annual General MeetingPrice sensitive
- Change of Director's Interest Notice
Dividend history
Dividends per share paid by Alcidion Group, by financial year.
| Financial year | Interim | Final | Special | Total |
|---|---|---|---|---|
| FY2026 | — | — | — | $0.5864 |
| FY2025 | — | — | — | $0.3334 |
| FY2024 | — | — | — | $0.2640 |
| FY2023 | — | — | — | $0.2360 |
| FY2022 | — | — | — | $0.2050 |
Key financials
Reported results for Alcidion Group, in AUD.
- Market cap
- 155.2M
- Revenue (TTM)
- 51.6M
- P/E ratio
- —
- EPS (diluted, TTM)
- 0.0
- Dividend yield
- —
- Profit margin
- 4.4%
| Fiscal year end | Revenue | Operating income | Net income |
|---|---|---|---|
| 51.6M | 2.6M | 2.3M | |
| 40.8M | 7.8M | 1.7M | |
| 37.1M | -7.6M | -8.4M | |
| 40.4M | -4.7M | -3.6M |